Atypical Neuroleptics

Contributing journals to this collection:
Academic Psychiatry, American Journal of Psychiatry, Focus, Journal of Neuropsychiatry, Psychiatric Services, and Psychosomatics

Citations 1-10 of 661 total displayed.

Most recent content

Reviews and Overviews
Clinical Trials Design Lessons From the CATIE Study

Helena Chmura Kraemer, Ira D. Glick, and Donald F. Klein
Am J Psychiatry 2009; 166: 1222-1228. [Abstract] [Full text] [PDF]  

Letters to the Editor
Ziprasidone and Citalopram Use in Pregnancy and Lactation in a Woman With Psychotic Depression

AMY WERREMEYER
Am J Psychiatry 2009; 166: 1298. [Full text] [PDF]  

Past content

Columns
Case Studies in Public-Sector Leadership: Implementing a Metabolic Initiative in a Community Mental Health Clinic

Dianna Dragatsi and Susan M. Deakins
Psychiatr Serv 2009; 60: 1298-1301. [Full text] [PDF]  

Reviews and Overviews
Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized Trials

J. Craig Nelson and George I. Papakostas
Am J Psychiatry 2009; 166: 980-991. [Abstract] [Full text] [PDF]  

Columns
Datapoints: Psychotropic Drug Prescriptions by Medical Specialty

Tami L. Mark, Katharine R. Levit, and Jeffrey A. Buck
Psychiatr Serv 2009; 60: 1167. [Full text] [PDF]  

Articles
Off-Label Use of Antipsychotic Medications in the Department of Veterans Affairs Health Care System

Douglas L. Leslie, Somaia Mohamed, and Robert A. Rosenheck
Psychiatr Serv 2009; 60: 1175-1181. [Abstract] [Full text] [PDF]  

Letters to the Editor
Drs. Mathew and Charney Reply

Sanjay J. Mathew and Dennis S. Charney
Am J Psychiatry 2009; 166: 934-a. [Full text] [PDF]  

Letters to the Editor
Publication Bias: Calling Academic Physicians to Account

SANDRA STEINGARD
Am J Psychiatry 2009; 166: 934. [Full text] [PDF]  

Letters to the Editor
Discontinuation of Quetiapine From an NIMH-Funded Trial Due to Serious Adverse Events

DILIP V. JESTE, HUA JIN, SHAHROKH GOLSHAN, SUNDER MUDALIAR, DANIELLE GLORIOSO, IAN FELLOWS, HELENA KRAEMER, and STEPHAN ARNDT
Am J Psychiatry 2009; 166: 937-938. [Full text] [PDF]  

REVIEW ARTICLES
Evidence for the Partial Dopamine-Receptor Agonist Aripiprazole as a First-Line Treatment of Psychosis in Patients With Iatrogenic or Tumorogenic Hyperprolactinemia

Zachary S. Hoffer, Richard L. Roth, and Maju Mathews
Psychosomatics 2009; 50: 317-324. [Abstract] [Full text] [PDF]  

[Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67